| Key Financial Ratios of Torrent Pharmaceuticals (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
55.46 |
44.05 |
28.48 |
50.48 |
102.99 |
|
| Diluted EPS (Rs.) |
55.46 |
44.05 |
28.48 |
50.48 |
102.99 |
|
| Cash EPS (Rs.) |
91.30 |
78.25 |
51.17 |
66.39 |
115.60 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
302.59 |
296.34 |
269.23 |
263.16 |
219.06 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
302.59 |
296.34 |
269.23 |
263.16 |
219.06 |
|
| Dividend / Share(Rs.) |
32.00 |
17.00 |
14.00 |
14.00 |
35.00 |
|
| Revenue from Operations/Share (Rs.) |
364.48 |
340.49 |
251.02 |
271.37 |
321.41 |
|
| PBDIT/Share (Rs.) |
127.27 |
117.88 |
73.25 |
84.30 |
173.39 |
|
| PBIT/Share (Rs.) |
91.42 |
83.67 |
50.57 |
68.39 |
160.78 |
|
| PBT/Share (Rs.) |
65.99 |
55.25 |
33.21 |
56.43 |
138.76 |
|
| Net Profit/Share (Rs.) |
55.45 |
44.05 |
28.48 |
50.47 |
102.99 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
34.91 |
34.62 |
29.18 |
31.06 |
53.94 |
|
| PBIT Margin (%) |
25.08 |
24.57 |
20.14 |
25.20 |
50.02 |
|
| PBT Margin (%) |
18.10 |
16.22 |
13.23 |
20.79 |
43.17 |
|
| Net Profit Margin (%) |
15.21 |
12.93 |
11.34 |
18.59 |
32.04 |
|
| Return on Networth / Equity (%) |
18.32 |
14.86 |
10.57 |
19.17 |
47.01 |
|
| Return on Capital Employed (%) |
18.20 |
15.84 |
5.45 |
12.38 |
30.12 |
|
| Return on Assets (%) |
7.89 |
6.19 |
4.07 |
10.61 |
23.91 |
|
| Total Debt/Equity (X) |
0.76 |
0.89 |
1.13 |
0.50 |
0.48 |
|
| Asset Turnover Ratio (%) |
51.90 |
47.91 |
35.94 |
57.04 |
74.63 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.13 |
1.21 |
1.22 |
3.07 |
2.09 |
|
| Quick Ratio (X) |
0.68 |
0.77 |
0.78 |
2.18 |
1.44 |
|
| Inventory Turnover Ratio (X) |
4.09 |
4.24 |
3.27 |
4.45 |
5.61 |
|
| Dividend Payout Ratio (NP) (%) |
64.91 |
40.86 |
45.63 |
19.80 |
40.04 |
|
| Dividend Payout Ratio (CP) (%) |
39.42 |
23.00 |
25.40 |
15.06 |
35.67 |
|
| Earnings Retention Ratio (%) |
35.09 |
59.14 |
54.37 |
80.20 |
59.96 |
|
| Cash Earnings Retention Ratio (%) |
60.58 |
77.00 |
74.60 |
84.94 |
64.33 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
36,888.48 |
37,267.78 |
26,214.00 |
28,350.03 |
24,374.98 |
|
| EV/Net Operating Revenue (X) |
5.98 |
6.47 |
6.17 |
6.17 |
4.48 |
|
| EV/EBITDA (X) |
17.13 |
18.68 |
21.15 |
19.87 |
8.31 |
|
| MarketCap/Net Operating Revenue (X) |
5.41 |
5.73 |
4.97 |
5.71 |
4.17 |
|
| Retention Ratios (%) |
35.08 |
59.13 |
54.36 |
80.19 |
59.95 |
|
| Price/BV (X) |
6.52 |
6.59 |
4.64 |
5.89 |
6.12 |
|
| Price/Net Operating Revenue |
5.41 |
5.73 |
4.97 |
5.71 |
4.17 |
|
| Earnings Yield |
0.03 |
0.02 |
0.02 |
0.03 |
0.08 |
|
Source : Dion Global Solutions Limited
